天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->84057-84-1

84057-84-1

84057-84-1 Structure

84057-84-1 Structure
IdentificationMore
[Name]

Lamotrigine
[CAS]

84057-84-1
[Synonyms]

3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE
6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE
BW-430C
GI 267119X
LAMICTAL
LAMOTRIGIN
LAMOTRIGINE
LAMOTRIGINE-13C1
LTG
4-triazine-3,5-diamine,6-(2,3-dichlorophenyl)-2
Lemotrigine
(2,3-Dichloro Phenyl)-1,2,4-triazine-3,5-diamine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, LTG, BW-430C, Lamictal
1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
LAMOTRINGINE
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, GI 267119X
BW-430
Lamotrigine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
[EINECS(EC#)]

281-901-8
[Molecular Formula]

C9H7Cl2N5
[MDL Number]

MFCD00865333
[Molecular Weight]

256.09
[MOL File]

84057-84-1.mol
Chemical PropertiesBack Directory
[Appearance]

White to Cream Coloured Powder
[Melting point ]

177-181°C
[Boiling point ]

503.1±60.0 °C(Predicted)
[density ]

1.572±0.06 g/cm3(Predicted)
[Fp ]

9℃
[storage temp. ]

2-8°C
[solubility ]

DMSO: 20 mg/mL at 60 °C, soluble
[form ]

powder
[pka]

5.7(at 25℃)
[color ]

white
[Usage]

An anticonvulsant. Inhibits glutamate release, possible through inhibition of Sodium, Potassium and Calcium currents
[Merck ]

14,5353
[BCS Class]

2
[InChI]

InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
[InChIKey]

PYZRQGJRPPTADH-UHFFFAOYSA-N
[SMILES]

N1C(C2=CC=CC(Cl)=C2Cl)=C(N)N=C(N)N=1
[CAS DataBase Reference]

84057-84-1(CAS DataBase Reference)
Safety DataBack Directory
[Hazard Codes ]

T,Xi
[Risk Statements ]

R25:Toxic if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin .
[Safety Statements ]

S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) .
S36:Wear suitable protective clothing .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
[RIDADR ]

UN 2811 6.1/PG 3
[WGK Germany ]

3
[RTECS ]

XY5850700
[HazardClass ]

6.1(b)
[PackingGroup ]

III
[HS Code ]

29336990
[Hazardous Substances Data]

84057-84-1(Hazardous Substances Data)
[Toxicity]

LD50 in mice, rats (mg/kg): 250, >640 orally (Sawyer)
Raw materials And Preparation ProductsBack Directory
[Raw materials]

Copper(I) Cyanide-->AMINOGUANIDINE-->2,3-Dichlorobenzoic acid-->2,3-Dichlorobenzoyl chloride-->Ethanol-->AMINOGUANIDINE HYDROCHLORIDE
Material Safety Data Sheet(MSDS)Back Directory
[msds information]

6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine(84057-84-1).msds
Hazard InformationBack Directory
[Description]

Lamotrigine, also known by the brand name Lamictal®, is a second-generation antiepileptic drug (AED) manufactured by GlaxoSmithKline in the UK and USA. Lamotrigine is a new mazine, glutamate inhibitor anticonvulsant that significantly reduces the incidence of refractory partial seizures. The drug is reported to produce fewer CNS side effects than diazepam or sodium phenytoin. It is also indicated as add-on therapy for the treatment of generalized seizures not satisfactorily controlled by other anti-epileptics.
[Chemical Properties]

White to Cream Coloured Powder
[Originator]

Burroughs Wellcome (United Kingdom)
[Uses]

Lamotrigine is an anticonvulsant that works by Inhibits glutamate release, possibly through inhibition of Sodium, Potassium, and Calcium currents. Used in the treatment of bipolar depression, partial seizures in epilepsy, and generalized seizures of Lennox-Gastaut syndrome. Additionally, it is used for the maintenance treatment of bipolar I disorder and depression.
[Definition]

ChEBI: Lamotrigine is a member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. It has a role as an anticonvulsant, an antimanic drug, an antidepressant, a non-narcotic analgesic, a calcium channel blocker, an excitatory amino acid antagonist, an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor, an environmental contaminant, a xenobiotic and a geroprotector. It is a member of 1,2,4-triazines, a primary arylamine and a dichlorobenzene.
[Preparation]

The preparation method of Lamotrigine involves several steps. 2,3-dichlorobenzoic acid is chlorinated to 2,3-dichlorobenzoyl chloride, then reacted with cuprous cyanide, condensed with aminoguanidine, and finally cyclized under the action of potassium hydroxide Lamotrigine.
Two key methods for the synthesis of lamotrigine have been reported.
https://www.sciencedirect.com/topics/chemistry/lamotrigine
A novel process for the synthesis of lamotrigine and its intermediate
https://patents.google.com/patent/WO2007069265A1/en
[Brand name]

Lamictal (Glax oSmithKline).
[Therapeutic Function]

Anticonvulsant
[World Health Organization (WHO)]

Lamotrigine is a relatively new antiepilepsy agent acting through stabilization of neuronal membranes and preventing liberation of neurotransmitters.
[Biological Functions]

Lamotrigine has a broad spectrum of action and is effective in generalized and partial epilepsies. Its primary mechanism of action appears to be blockage of voltagedependent sodium channels, although its effectiveness against absence seizures indicates that additional mechanisms may be active. Lamotrigine is almost completely absorbed from the gastrointestinal tract, and peak plasma levels are achieved in about 2 to 5 hours. The plasma half-life after a single dose is about 24 hours. Unlike most drugs, lamotrigine is metabolized primarily by glucuronidation. Therefore, it appears likely that lamotrigine will not induce or inhibit cytochrome P450 isozymes, in contrast to most AEDs.
[General Description]

Lamotrigine(84057-84-1) is an antiepileptic drug belonging in the phenyltriazine class. It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. Lamotrigine is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. It is approved for use in more than 30 countries.
[Biological Activity]

Anticonvulsant. Inhibits glutamate release, possibly through inhibition of Na + , K + and Ca 2+ currents.
[Mechanism of action]

Lamotrigine has been found effective against refractory partial seizures. Like phenytoin and CBZ, its main mechanism of action appears to be a blockade of sodium channels that is both voltage- and used-dependent. It also inhibits the high-threshold calcium channel, possibly through inhibition of presynaptic N-type calcium channels, and also blocks glutamate release. The most probable explanation for lamotrigine's efficacy is its ability to produce a blockade of sodium channel repetitive firing. In addition, lamotrigine appears to reduce glutaminergic excitatory transmission, although the mechanism for this action remains unclear.
[Pharmacokinetics]

Following oral administration, lamotrigine is absorbed rapidly and completely, exhibiting linear pharmacokinetics and modest protein binding (55%). Lamotrigine is metabolized predominantly by N-glucuronidation and subsequent urinary elimination of its major metabolite, the quaternary 2-N-glucuronide (80–90%), the minor 5-amino-N-glucuronide (8–10%), and unchanged drug (8–10%). Lamotrigine's usual elimination half-life of 24–35 hours is reduced to 13–15 hours in patients taking enzymeinducing AEDs. The presence of valproate increases the lamotrigine half-life substantially by inhibiting N-glucuronidation, necessitating a reduction in dose to avoid toxicity. Hepatic disease patients may demonstrate a reduced capacity to for lamotrigine glucuronidation, thus reducing its rate of clearance.
[Clinical Use]

Lamotrigine is a 5-phenyl-1,2,4-triazine derivative indicated as monotherapy or as an adjunct for partial seizures in adults, as adjunct in patients with Lennox-Gastaut syndrome, and as adjunct for partial seizures in children 2 years of age and older. Lamotrigine may have additional benefit in combating myoclonic and typical absence seizures. It is approved for use in the maintenance treatment of bipolar disorder.
[Side effects]

The usefulness of lamotrigine is limited by the increased incidence of serious rashes, particularly in children or patients taking valproate. This increase, however, may be attenuated by very slow dose escalation, because most rashes appear within the first 8 weeks of treatment. The drug should be discontinued if a rash appears at any time. Additionally, lamotrigine may be associated with development of myoclonus after 2 to 3 years of drug treatment. Additional common side effects associated with lamotrigine therapy include dizziness, diplopia, headache, ataxia, blurred vision, somnolence, and nausea.
[Synthesis]

The reaction of the Grignard compound of 2,3-dichloroiodobenzene with CO2 in diethyl ether gives 2,3-dichlorobenzoic acid, which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2,3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2,3-dichlorobenzoyl cyanide. Finally, this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine .
Synthesis_84057-84-1
[Drug interactions]

Potentially hazardous interactions with other drugs Antibacterials: concentration reduced by rifampicin. Antidepressants: antagonism of anticonvulsant effect; avoid with St John’s wort. Antiepileptics: concentration reduced by carbamazepine, phenobarbital and phenytoin, also possibility of increased concentration of active carbamazepine metabolite; concentration increased by valproate - reduce lamotrigine dose. Antimalarials: mefloquine antagonises anticonvulsant effect Antipsychotics: anticonvulsant effect antagonised. Oestrogens and progestogens: concentration of lamotrigine reduced and the dose may need to be increased by as much as 2-fold; may affect contraceptive effect. Orlistat: possibly increased risk of convulsions
[Metabolism]

Lamotrigine is extensively metabolised in the liver by UDP-glucuronyl transferases and excreted almost entirely in urine, principally as an inactive glucuronide conjugate. It slightly induces its own metabolism. Only about 2% of lamotrigine-related material is excreted in faeces.
[storage]

Room temperature
[References]

https://my.clevelandclinic.org/health/drugs/20217-lamotrigine-tablets
https://pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine
https://go.drugbank.com/drugs/DB00555
The_Renal_Drug_Handbook_The_Ultimate
Spectrum DetailBack Directory
[Spectrum Detail]

Lamotrigine(84057-84-1)1HNMR
Well-known Reagent Company Product InformationBack Directory
[Sigma Aldrich]

84057-84-1(sigmaaldrich)
84057-84-1 suppliers list
Company Name: Hebei Zhanyao Biotechnology Co. Ltd
Tel: 15369953316 +8615369953316 , +8615369953316
Website: www.approvedhomemanagement.com/ShowSupplierProductsList1218991/0.htm
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525 , +8618327326525
Website: topule.com/
Company Name: Hebei Mojin Biotechnology Co., Ltd
Tel: +86 13288715578 +8613288715578 , +8613288715578
Website: http://www.mojinchemical.com
Company Name: HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Tel: +8615350851019 , +8615350851019
Website: www.86-ss.com/
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512 , +86-19937530512
Website: https://www.tianfuchem.com/
Company Name: Shanghai Zheyan Biotech Co., Ltd.
Tel: 18017610038
Website: www.approvedhomemanagement.com/ShowSupplierProductsList30845/0.htm
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695 , +8613203830695
Website: www.coreychem.com/
Company Name: Hubei Jusheng Technology Co.,Ltd.
Tel: 18871490254
Website: www.hubeijusheng.com
Company Name: Casorganics US Corp
Tel: +17326109938
Website: www.approvedhomemanagement.com/ShowSupplierProductsList31338/0.htm
Company Name: Xiamen AmoyChem Co., Ltd
Tel: +86-86-5926051114 +8618959220845 , +8618959220845
Website: www.amoychem.com/
Company Name: BOC Sciences
Tel: +1-631-485-4226
Website: www.bocsci.com/
Company Name: Chongqing Chemdad Co., Ltd
Tel: +86-023-6139-8061 +86-86-13650506873 , +86-86-13650506873
Website: http://www.chemdad.com/
Company Name: Alchem Pharmtech,Inc.
Tel: 8485655694
Website: www.approvedhomemanagement.com/ShowSupplierProductsList454175/0.htm
Company Name: CONIER CHEM AND PHARMA LIMITED
Tel: +8618523575427 , +8618523575427
Website: http://www.conier.com/
Company Name: SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel: +86-021-61551413 +8618813727289 , +8618813727289
Website: http://www.trustwe.com/
Company Name: Hebei Binshare New Material Co. Ltd
Tel: +8618633865755 , +8618633865755
Website: https://www.binsharematerial.com/
Company Name: WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
Tel: +8615377521700 , +8615377521700
Website: http://www.approvedhomemanagement.com/manufacturer/wuhan-circle-powder-technology-306/
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Tags:84057-84-1 Related Product Information
94213-24-8 77668-42-9 35022-44-7 35022-43-6 136565-76-9 661463-79-2 50-45-3 94213-23-7 38943-76-9 7568-93-6 37764-25-3 80-10-4 149-74-6 290-87-9 107-15-3 84057-84-1